Journal of Cancer Survivorship最新文献

{"title":"Income, race, and cardiovascular disease in female breast cancer survivors: evidence of moderated socioeconomic protection in the National Health Interview Survey (NHIS) 2019-2022.","authors":"Robina Josiah Willock, Daniel Parks, Samah Nabi, Brian Rivers, Desiree Rivers, Chaohua Li, Phillip Levy","doi":"10.1007/s11764-026-02112-3","DOIUrl":"https://doi.org/10.1007/s11764-026-02112-3","url":null,"abstract":"<p><p>Cardiovascular disease (CVD) remains a leading cause of poor outcomes among breast cancer survivors. Treatment contributes to both acute and long-term CVD risk, but social determinants of health (SDoH), like economic deprivation, also compound vulnerability. This study examined the associations between poverty-to-income ratio (PIR) and self-reported CVD in a national sample of breast cancer survivors.</p><p><strong>Methods: </strong>Using National Health Interview Survey (NHIS) data from 2019 to 2022, we examined sociodemographic characteristics, health behaviors, and comorbidities in a sample of 2745 female breast cancer survivors. We tested IPTW-adjusted logistic models for associations between PIR and CVD prevalence and interactions by race, age, years of survivorship, and delayed medical care.</p><p><strong>Results: </strong>Higher income did not protect survivors equally. The protection of higher PIR was significantly modified by race/ethnicity (p < 0.0001). Higher PIR reduced the odds of CVD 92% among Black survivors, compared to 68% among White survivors, with no significant association among Asian survivors. The protection of higher PIR was greatest among survivors aged < 65 years and lessened progressively up to ≥ 85 years (p = 0.017). The overall interaction terms were non-significant (p > 0.05) for years of breast cancer survivorship and approached significance for delayed care-seeking.</p><p><strong>Conclusions: </strong>PIR emerged as a robust predictor of comorbid CVD with strongest protection among younger, racial/ethnic minority, and early-survivorship subgroups.</p><p><strong>Implications for cancer survivors: </strong>Clinical CVD risk models in breast cancer remain underspecified when measures of economic status are excluded. These findings support extending clinical guidance for CVD prevention beyond the current 5-year threshold and integrating economic screening into survivorship care.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148891837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Illness perceptions and symptom burden in chemotherapy-induced peripheral neuropathy: a moderated mediation analysis from a self-regulatory perspective.","authors":"Qingchun Geng, Xiang Gao, Qian Zhao, Hongwen Ma, Ruoyi Xu, Jun Luo, Chulei Tang, Yanfei Jin","doi":"10.1007/s11764-026-02081-7","DOIUrl":"https://doi.org/10.1007/s11764-026-02081-7","url":null,"abstract":"<p><strong>Purpose: </strong>Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent and often persistent adverse effect that contributes to substantial symptom burden and psychological distress among cancer survivors. However, the self-regulatory mechanisms linking patients' illness perceptions to these outcomes remain poorly understood. Guided by the Common-Sense Model of self-regulation, this study examined whether positive coping mediates the associations between illness perceptions and CIPN-related symptom burden and psychological distress, and whether mindfulness moderates these pathways.</p><p><strong>Methods: </strong>A two-center cross-sectional survey enrolled 563 adults receiving platinum-based chemotherapy who reported CIPN symptoms. Validated questionnaires assessed CIPN symptom severity, psychological distress, illness perceptions, positive coping, mindfulness, and physical activity. Structural equation modeling with bootstrapping tested mediation and moderated mediation, adjusting for covariates.</p><p><strong>Results: </strong>More threatening illness perceptions were significantly associated with greater CIPN symptom burden and higher psychological distress. Positive coping partially mediated these associations, accounting for 51% of the total association with symptom burden and 37% with psychological distress. Mindfulness moderated key pathways, indicating that the strength of associations between illness perceptions, coping, and outcomes varied according to mindfulness levels.</p><p><strong>Conclusions: </strong>These findings support a self-regulatory framework in which illness perceptions influence CIPN-related physical and psychological outcomes partly through coping processes, while mindfulness shapes vulnerability across pathways.</p><p><strong>Implications for cancer survivors: </strong>Interventions targeting illness perceptions, coping skills, and mindfulness may help cancer survivors better manage CIPN symptoms and psychological distress, thereby supporting more comprehensive survivorship care.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148891809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demystifying financial toxicity measures: semi-structured interviews comparing COST-FACIT and ENRICh among cancer survivors on targeted oral anticancer medications (TOAMs).","authors":"Lisa M Lowenstein, Maria P Bernal, Erik P Bergren, Taahir K Busaidy, Eden R Brauer, Patricia A Ganz, Grace L Smith, Ya-Chen Tina Shih","doi":"10.1007/s11764-026-02109-y","DOIUrl":"https://doi.org/10.1007/s11764-026-02109-y","url":null,"abstract":"<p><strong>Purpose: </strong>Despite increasing efforts to address financial toxicity among patients with cancer, approaches to best identify patients for targeted intervention remain unclear. We compared qualitative accounts of financial toxicity among patients receiving targeted oral anticancer medications (TOAMs) to their scores in two screening tools, the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (COST-FACIT) and the Economic Strain and Resilience in Cancer (ENRICh).</p><p><strong>Methods: </strong>We conducted mixed-methods analysis of adult patients at a comprehensive cancer center. Patients had confirmed cancer diagnoses and orders for TOAMs in the last 3 months. Participants completed surveys (n = 108), and a subset with COST-FACIT scores indicating financial toxicity participated in semi-structured interviews (n = 20). We applied the Framework Method to examine qualitative accounts and developed joint matrices to assess how well each measure identified financial toxicity.</p><p><strong>Results: </strong>Qualitative accounts highlighted two elements of financial toxicity: financial strain and financial worry. For participants with extreme accounts of financial strain and financial worry (n = 6), COST-FACIT and ENRICh scores indicated medium to high levels of financial toxicity. For the rest (n = 14), qualitative accounts of financial strain and financial worry were not completely captured by COST-FACIT and/or ENRICh.</p><p><strong>Conclusion: </strong>Our findings suggest a single measure may not adequately identify financial toxicity and differentiate between strain and worry. A stepwise, wholistic approach may better identify and connect patients to appropriate resources.</p><p><strong>Implications for cancer survivors: </strong>Interventions that address financial toxicity in this group may need to use more than one measure to identify and route patients to targeted intervention.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148891820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Activity profiles and their correlates in patients with localised renal and colorectal cancer shortly after treatment: a cross-sectional analysis.","authors":"Annemone Siffels, Martijn J L Bours, Eline H van Roekel, Matty P Weijenberg, J P Michiel Sedelaar, Stéphanie O Breukink, Eric T P Keulen, Maryska Janssen-Heijnen, Koen G Frenken, Katja K H Aben, Jake S F Maurits, Lambertus A L M Kiemeney, Laurien M Buffart, Alina Vrieling","doi":"10.1007/s11764-026-02106-1","DOIUrl":"https://doi.org/10.1007/s11764-026-02106-1","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study is to identify activity profiles and their correlates in patients with localised renal cell carcinoma (RCC) and colorectal cancer (CRC) shortly after treatment completion.</p><p><strong>Methods: </strong>In the ReLife (n = 326 patients with RCC) and EnCoRe (n = 358 patients with CRC) studies, we measured physical activity and sedentary behaviour at 3 months and 6 weeks after treatment completion using accelerometers. We used latent profile analyses to determine activity profiles. Demographic, lifestyle-related, and clinical correlates were investigated with multinomial regression analyses.</p><p><strong>Results: </strong>We identified three activity profiles for both populations: a most sedentary (RCC:28%, CRC:16%), an average (RCC:50%, CRC:53%), and a highly active profile (RCC:22%, CRC:31%). In the most sedentary profile, mean sedentary time was 11.9 h/day for RCC and 13.1 h/day for CRC, while mean physical activity was 72 min/day and 44 min/day, respectively. Correlates of the most sedentary profile were male sex (RCC: odds ratio (OR), 2.18; 95% confidence interval [95%CI], 1.06-4.47), and higher fatigue scores (per 1 point: RCC, 0.98 [0.96-1.00]; CRC, 0.98 [0.96-0.99]). Correlates of the highly active profile were male sex (CRC, 0.38 [0.20-0.71]), higher educational level (RCC, 0.31 [0.14-0.72]; CRC, 0.46 [0.22-0.96]), and higher BMI (per 1 kg/m²: RCC, 0.91 [0.84-0.99]; CRC, 0.92 [0.86-0.99]).</p><p><strong>Conclusions: </strong>There are distinct activity profiles in patients with RCC and CRC. Male sex, higher education, higher BMI, and lower fatigue score were associated with less favourable profiles.</p><p><strong>Implications for cancer survivors: </strong>These findings highlight that activity profiles in patients with RCC and CRC are heterogeneous, which should be considered when promoting healthy lifestyles.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148887631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Examination of insurance type and cancer treatments with administrative burdens and financial toxicity in a sample of cancer survivors.","authors":"Ada Z Lu, Jean C Yi, Nora B Henrikson, Laura E Panattoni, Diana Lowry, Kendall Harkey, Salene M W Jones","doi":"10.1007/s11764-026-02116-z","DOIUrl":"https://doi.org/10.1007/s11764-026-02116-z","url":null,"abstract":"<p><strong>Purpose: </strong>Many cancer survivors experience administrative burdens and poor financial outcomes but associations with insurance and cancer treatments are not well studied. This study aimed to fill that gap.</p><p><strong>Methods: </strong>Cancer survivors (n = 459), on average 11 years post-diagnosis and in the United States completed a cross-sectional survey. Dependent variables were five types of insurance-related administrative burdens (prior authorization, denials, surprise bills, stepped care, out-of-network care) and four dimensions of financial toxicity. Independent variables were health insurance type at diagnosis and cancer treatments. Logistic and linear regression models assessed the relationships between independent and dependent variables.</p><p><strong>Results: </strong>Forty-six percent reported at least one insurance-related administrative burden. Participants who received immunotherapy (prior authorizations: 33%; surprise bills: 46%; stepped care: 26%), chemotherapy (denial: 22%; stepped care: 17%), surgery (surprise bills: 33%; out-of-network: 16%) and radiation therapy (denials: 24%) reported significantly higher prevalence of administrative burdens than those who had not received those treatments (p's < 0.05). Insurance type was not associated with administrative burdens (p's > 0.05). Surgery, chemotherapy and immunotherapy were associated with more financial coping than those who did not receive these treatments (p's < 0.025). Compared to employer/school-sponsored insurance, most insurance types were not associated with financial toxicity except self-purchased insurance was associated with more financial depression, anxiety and coping (p's < 0.05).</p><p><strong>Conclusions: </strong>Patient-reported administrative burden may be associated with all types of insurance and survivors may respond with more financial coping.</p><p><strong>Implications for cancer survivors: </strong>Immunotherapy and chemotherapy may have the highest risk for administrative burdens but surgery and radiation therapies can also confer risk.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148887618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Survivorship care for melanoma patients: a scoping review.","authors":"Madlen Hörold, Sasha Schutkowski, Karl-Philipp Drewitz, Sebastian Haferkamp, Jochen Schmitt, Friedegund Meier, Maike Bergmann, Benjamin Küster, Marlon Pape, Christian Apfelbacher","doi":"10.1007/s11764-026-02067-5","DOIUrl":"https://doi.org/10.1007/s11764-026-02067-5","url":null,"abstract":"<p><strong>Purpose: </strong>Despite significant advances in melanoma treatment, many survivors continue to experience long-term effects of disease and therapy. Various survivorship care programs have been developed in recent years, but these differ in terms of their scope, content, and delivery. The aim of this scoping review was to summarize existing literature on melanoma survivorship care.</p><p><strong>Methods: </strong>The search strategy was developed using the PCC (Population, Concept, Context) framework for scoping reviews. We conducted systematic searches in MEDLINE®, the Cochrane Library, Web of Science and CINAHL for studies published between 01/2015 and 03/2026. Additionally, the reference lists of the included studies were screened. Two researchers conducted the searches independently. They screened the studies using defined criteria and extracted data on study characteristics and the reported care. The results were summarized using the content analysis by Elo and Kyngäs.</p><p><strong>Results: </strong>Of the 2,993 references screened, 21 studies met the inclusion criteria and covered seven unique survivorship care programs. These studies were published from 2015 onward. Using the domains of the Cancer survivorship care quality framework, we characterized the studies as follows: prevention and monitoring of recurrence and new cancers; monitoring and management of physical, psychosocial, and chronic conditions; health promotion and disease prevention; and context-related domains of the healthcare system, such as clinical structure, communication and decision making, and care coordination.</p><p><strong>Conclusion: </strong>This scoping review summarizes the current melanoma survivorship care. Evidence gaps remain, particularly regarding health literacy and health economic perspectives.</p><p><strong>Implication for cancer survivors: </strong>The findings will support the development of a patient-centered survivorship care program for people living with and beyond melanoma.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148887678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond race and ethnicity: a scoping review of supportive care needs and barriers for immigrant AYA cancer survivors.","authors":"Ana Cardeña-Gutiérrez, Mary Tanay, Paula Rodríguez-Hernáez, Changchuan Jiang, Nicolas H Hart, Enrique Soto-Perez-de-Celis, Alexandre Chan","doi":"10.1007/s11764-026-02094-2","DOIUrl":"https://doi.org/10.1007/s11764-026-02094-2","url":null,"abstract":"<p><strong>Purpose: </strong>To map the current literature regarding the unmet supportive care needs, structural barriers, and healthcare transition challenges faced by immigrant adolescent and young adult (AYA) cancer survivors.</p><p><strong>Methods: </strong>Following JBI methodology and PRISMA-ScR guidelines, a systematic search was conducted across major databases (including PubMed and Embase) to identify peer-reviewed studies focusing on foreign-born or immigrant AYA cancer survivors (aged 15-39) and their long-term survivorship experiences.</p><p><strong>Results: </strong>Six studies met the inclusion criteria. Immigrant AYAs face a compounding matrix of linguistic, financial, and legal barriers that limit healthcare access. The transition from pediatric to adult oncology highlights a profound disconnect between individualistic Western healthcare models and collectivist, family-centered decision-making norms. Furthermore, post-migration acculturation processes sometimes erode baseline healthy behaviors, worsening financial toxicity and long-term psychosocial outcomes.</p><p><strong>Conclusions: </strong>Current survivorship frameworks fail to adequately account for the migratory process, often conflating immigration status with broad racial categories. Systemic changes are required in oncology research to capture granular data on nativity and length of residency to expose and address these hidden disparities.</p><p><strong>Implications for cancer survivors: </strong>Culturally responsive survivorship programs, dedicated language services, and family-inclusive patient navigation models are essential to prevent care attrition, reduce post-treatment social stigma, and ultimately optimize the long-term quality of life for immigrant AYA survivors.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"One step forward, two steps back: a qualitative study of clinical perspectives on implementing exercise in neuro-oncology care.","authors":"Julia T Daun, Gloria Roldan Urgoiti, Mannat Bansal, Meghan H McDonough, Lauren C Capozzi, Jacob C Easaw, Margaret L McNeely, George J Francis, S Nicole Culos-Reed","doi":"10.1007/s11764-026-02113-2","DOIUrl":"https://doi.org/10.1007/s11764-026-02113-2","url":null,"abstract":"<p><strong>Background: </strong>Neuro-oncology care lacks an exercise referral pathway and tailored exercise programming. The Alberta Cancer Exercise-Neuro-Oncology (i.e., ACE-Neuro) study was implemented and evaluated for feasibility and effectiveness to address this lack of resources. The purpose of the present study was to understand healthcare provider, exercise specialist, and cancer care administrator perspectives on the role of exercise in neuro-oncology.</p><p><strong>Methods: </strong>A qualitative study design using interpretive description was conducted. Clinical team members involved in the referral to and delivery of ACE-Neuro were invited for a semi-structured interview. Interviews were scheduled either in-person or remotely. Analysis was conducted by a transdisciplinary team including collaboration with a neuro-oncology clinical partner.</p><p><strong>Results: </strong>A total of n = 10 clinical team members participated. Mean interview length was 35:44 ± 17.49 min. Three themes were created during analyses: (1) The Gateway: Optimizing Exercise Referral in Neuro-Oncology, (2) The Building Blocks: Championing a Tailored Neuro-Oncology Exercise Model, and (3) Beyond the Short-Term: Neuro-Oncology Needs a Stronger Voice in Funding and Policy. These themes highlight that the clinical team perceived an electronic medical record referral pathway as feasible, tailored exercise is non-negotiable for neuro-oncology patients, and funding and policy were identified as major barriers to sustainable exercise programming.</p><p><strong>Conclusion: </strong>This study offers new insights into how exercise is implemented within neuro-oncology care from the clinical perspective. A systematic focus on optimizing referral pathways, championing the delivery of personalized programming, and bridging policy and system-level strategies for long-term program sustainability are key to advancing the field of neuro-oncology.</p><p><strong>Implications for cancer survivors: </strong>From the perspective of clinicians, integrating exercise into routine neuro-oncology care requires methodical referral pathways and tailored exercise program delivery. Clinicians also believe that long-term sustainability will require administrative and policy support to ensure access to supportive care resources for those living with brain cancer. These implementation strategies have the potential to improve patient access to evidence-based and individualized neuro-oncology exercise resources.</p><p><strong>Clinical trials registration: </strong>NCT04831190 ( https://clinicaltrials.gov/study/NCT04831190 ).</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A mixed-methods systematic review of the psycho-social outcomes and experiences of therapeutic tattooing for cancer survivors.","authors":"Adam Daly, Isobel Walsh, Johannes Karl, Pamela Gallagher, Simon Dunne","doi":"10.1007/s11764-026-02114-1","DOIUrl":"https://doi.org/10.1007/s11764-026-02114-1","url":null,"abstract":"<p><strong>Purpose: </strong>Increasing rates of cancer survivorship suggest more individuals will face the challenges associated with living in a changed body post-treatment. Therapeutic tattooing is an intervention to address these challenges. However, no previous systematic review has synthesised the existing evidence on the psycho-social outcomes and experiences of cancer survivors who have received therapeutic tattoos. This review addresses this important gap within the literature.</p><p><strong>Methods: </strong>Seven databases were searched in this systematic review: PsycINFO, Medline, CINAHL, Embase, PubMed, Scopus, and Web of Science to identify qualitative, quantitative and mixed-methods studies that examined the psycho-social outcomes and experiences of therapeutic tattoos for cancer survivors. A convergent integrated thematic synthesis was conducted to synthesise qualitative and quantitative data.</p><p><strong>Results: </strong>Sixteen studies were included (6 qualitative, 10 quantitative), representing data from over 747 tattooed cancer survivors across diverse cancer types. Six themes related to the psycho-social outcomes and experiences of therapeutically tattooed cancer survivors were identified: (1) fulfilment, (2) wellbeing, (3) feelings about one's body, (4) perceived design quality, (5) processing feelings about cancer, and (6) reconceptualised identities.</p><p><strong>Conclusion: </strong>The findings of this review highlight that therapeutic tattoos can impact cancer survivors in several ways, positively and negatively. However, there is a limit to both the breadth and depth of the current understanding of these tattoos as a whole despite growing popularity.</p><p><strong>Implications for cancer survivors: </strong>Advancing our understanding of therapeutic tattooing will empower cancer survivors to make more informed decisions about the practice and their bodies following treatment. Our review has identified several positive and negative psychosocial outcomes/experiences which may come from receiving a therapeutic tattoo. However, further research is needed to guide policy and training in this practice to better support and protect interested cancer survivors.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sustained effects of auricular point acupressure on chemotherapy-induced neuropathy: a randomized controlled trial follow-up study.","authors":"Nada Lukkahatai, Yannuo Jiang, Jingyu Zhang, Jennifer Kawi, Hulin Wu, Hongyu Wang, Claudia M Campbell, Johannes Thrul, Salahadin Abdi, Eileen D Hacker, Constance M Johnson, Thomas J Smith","doi":"10.1007/s11764-026-02104-3","DOIUrl":"https://doi.org/10.1007/s11764-026-02104-3","url":null,"abstract":"<p><strong>Purpose: </strong>Chemotherapy-induced neuropathy (CIN) is a persistent condition that impairs function and quality of life. Auricular point acupressure (APA) has shown short-term benefit for CIN, but the durability of these effects after treatment completion is unknown. This study evaluated the sustainability of symptom improvements for 3 months following a 4-week APA intervention.</p><p><strong>Methods: </strong>This prespecified secondary analysis of a randomized wait-list controlled trial compared mobile-supported APA (mAPA) and virtual APA (vAPA) in adults with moderate or greater CIN who received APA during the initial treatment phase (mAPA, n = 80; vAPA, n = 75). Outcomes at 1, 2, and 3 months post-intervention were analyzed using generalized estimating equations with multiple imputation. The primary outcome was CIN severity, measured with an individualized composite outcome (ICO); the secondary outcome was CIN interference.</p><p><strong>Results: </strong>Reductions in CIN severity and interference were maintained throughout follow-up in both groups (all p < .001). ICO scores decreased by 3.10, 3.36, and 3.61 points in mAPA and by 2.88, 2.90, and 3.21 points in vAPA at 1, 2, and 3 months, respectively. Benefits were maintained post-treatment, with higher retention in the mAPA group.</p><p><strong>Conclusions: </strong>Improvements in CIN severity and interference after APA were sustained for up to 3 months post-treatment, suggesting a durable benefit as a self-management strategy. Larger studies with longer follow-up and untreated comparison groups are needed.</p><p><strong>Implications for cancer survivors: </strong>APA may offer survivors a durable, self-administered, nonpharmacologic option for managing CIN well beyond active treatment, without requiring ongoing clinical visits.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov, ID NCT04920097 registered on 3 June 2021.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148874155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}